Help, hope and hype: ethical considerations of human microbiome research and applications

Protein and Cell

Volumn 9, Issue 5, 2018, Pages 404-415

  Ma, Yonghui ^a   Chen, Hua ^b   Lan, Canhui ^c   Ren, Jianlin ^a,d  

^a XIAMEN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c Beijing Rexinchang Biotechnology Research Institute Co Ltd   (China)

^d ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENVIRONMENTAL FACTOR; FECAL MICROBIOTA TRANSPLANTATION; GENOME; HEREDITY; HIGH THROUGHPUT SCREENING; HUMAN; INTESTINE FLORA; MEDICAL ETHICS; MEDICAL RESEARCH; MICROBIAL COMMUNITY; MICROBIOME; NOTE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH SERVICE; RISK FACTOR; ETHICS; METHODOLOGY; MICROFLORA; STANDARDS;

BIOMEDICAL RESEARCH; HUMANS; MICROBIOTA; RESEARCH DESIGN;

EID: 85045732500     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-018-0537-4     Document Type: Note

References (77)

1. Balskus EP (2016) Addressing infectious disease challenges by investigating microbiomes. ACS Infect Dis 2(7):453–455
2. Bannaga AS, Selinger CP (2015) Inflammatory bowel disease and anxiety: links, risks, and challenges faced. Clin Exp Gastroenterol 8:111–117
3. Best is yet to come (2011) Nature 470:140. https://www.nature.com/articles/470140a
4. Bik EM (2016) The hoops, hopes, and hypes of human microbiome research. Yale J Biol Med 89(3):363–373
5. Bledsoe MJ (2017) Ethical legal and social issues of biobanking: past, present, and future. Biopreserv Biobank 15(2):142–147
6. Bolan S, Seshadri B, Talley NJ, Naidu R (2016) Bio-banking gut microbiome samples. EMBO Rep 17(7):929–930
7. Borody TJ, Campbell J (2012) Fecal microbiota transplantation: techniques, applications, and issues. Gastroenterol Clin N Am 41(4):781–803
8. Brownsword R, Wale J (2017) The right to know and the right not to know revisited: part one. Asian Bioeth Rev 9(1):3–18
9. Burke W, Burton H, Hall AE, Karmali M, Khoury MJ, Knoppers B, Meslin EM, Stanley F, Wright CF, Zimmern RL (2010) Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine? Genet Med 12(12):785–791
10. Cambon-Thomsen A (2004) The social and ethical issues of post-genomic human biobanks. Nat Rev Genet 5(11):866–873
11. Cammarota G, Ianiro G, Gasbarrini A (2014) Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol 48(8):693–702
12. Caulfield T (2007) Biobanks and blanket consent: the proper place of the public good and public perception rationales. King’s Law J 18(2):209–226
13. Chen Y, Blaser MJ (2007) Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 167(8):821–827
14. Chu DM, Ma J, Prince AL, Antony KM, Seferovic MD, Aagaard KM (2017) Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat Med 23:314
15. Chuong KH, Hwang DM, Tullis DE, Waters VJ, Yau YC, Guttman DS, O’Doherty KC (2017) Navigating social and ethical challenges of biobanking for human microbiome research. BMC Med Ethics 18(1):1
16. Collins FS (1999) Shattuck lecture–medical and societal consequences of the human genome project. N Engl J Med 341(1):28–37
17. Costello SP, Tucker EC, La Brooy J, Schoeman MN, Andrews JM (2016) Establishing a fecal microbiota transplant service for the treatment of clostridium difficile infection. Clin Infect Dis 62(7):908–914
18. Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13(10):701–712
19. Cunnington AJ, Sim K, Deierl A, Kroll JS, Brannigan E, Darby J (2016) “Vaginal seeding” of infants born by caesarean section. BMJ 352
20. Dethlefsen L, McFall-Ngai M, Relman DA (2007) An ecological and evolutionary perspective on human–microbe mutualism and disease. Nature 449:811
21. Dominguez-Bello MG, Blaser MJ (2011) The human microbiota as a marker for migrations of individuals and populations. Ann Rev Anthropol 40(1):451–474
22. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci 107(26):11971
23. Emanuel EJ, Wendler D, Grady C (2000) What makes clinical research ethical? Jama 283(20):2701–2711
24. Francis LP, Battin MP, Jacobson JA, Smith CB, Botkin J (2005) How infectious diseases got left out–and what this omission might have meant for bioethics. Bioethics 19(4):307–322
25. Franzosa EA, Huang K, Meadow JF, Gevers D, Lemon KP, Bohannan BJ (2015) Identifying personal microbiomes using metagenomic codes. Proc Natl Acad Sci USA, 112
26. Gligorov N (2013) Privacy, confidentiality, and new ways of knowing more. In: The human microbiome: Ethical, legal and social concerns (Edited by Rosamond Rhodes, Nada Gligorov, Abraham Paul Schwab). Oxford University Press
27. Gligorov N, Azzouni J, Lackey DP, Zweig A (2013) Personal Identity: our microbes, ourselves. In: The human microbiome: ethical, legal and social concerns, Edited by Prosamond Rhodes, Nada Gligorov, And Abraham Paul Schwab, Oxford University Press
28. Hampton-Marcell JT, Lopez JV, Gilbert JA (2017) The human microbiome: an emerging tool in forensics. Microb Biotechnol 10(2):228–230
29. Hanage WP (2014) Microbiology: microbiome science needs a healthy dose of scepticism. Nature 512(7514):247–248
30. Harrison KL, Farrell RM, Brinich MA, Highland J, Mercer M, McCormick JB, Tilburt J, Geller G, Marshall P, Sharp RR (2015) ‘Someone should oversee it’: patient perspectives on the ethical issues arising with the regulation of probiotics. Health Expect 18(2):250–261
31. Hawkins AK, O’Doherty KC (2011) “Who owns your poop?”: insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies. BMC Med Genom 4:72
32. Honey K (2008) Good bugs, bad bugs: learning what we can from the microorganisms that colonize our bodies. J Clin Invest 118(12):3817
33. Hutter T, Gimbert C, Bouchard F, Lapointe F-J (2015) Being human is a gut feeling. Microbiome 3:9
34. Juengst ET, Settersten RA, Fishman JR, McGowan ML (2012) After the revolution? Ethical and social challenges in ‘personalized genomic medicine’. Pers Med 9(4):429–439
35. Lederberg J (2006) The microbe’s contribution to biology–50 years after. Int Microb 9(3):155–156
36. Lu C, Sang J, He H, Wan X, Lin Y, Li L, Li Y, Yu C (2016) Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis. Sci Rep 6:23522
37. Ma B, Forney LJ, Ravel J (2012) The vaginal microbiome: rethinking health and diseases. Ann Rev Microbiol 66:371–389
38. Ma Y, Liu J, Rhodes C, Nie Y, Zhang F (2017a) Ethical issues in fecal microbiota transplantation in practice. Am J Bioeth 17(5):34–45
39. Ma Y, Chen H, Lei R, Ren J (2017b) Biobanking for human microbiome research: promise, risks, and ethics. Asian Bioeth Rev 9(4):311–324
40. Ma Y, Yang J, Cui B, Xu H, Xiao C, Zhang F (2017c) How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation: a questionnaire study. BMC Med Ethics 18(1):39
41. McGuire AL, Colgrove J, Whitney SN, Diaz CM, Bustillos D, Versalovic J (2008) Ethical, legal, and social considerations in conducting the human microbiome project. Genome Res 18(12):1861–1864
42. McGuire AL, Achenbaum LS, Whitney SN, Slashinski MJ, Versalovic J, Keitel WA, McCurdy SA (2012) Perspectives on human microbiome research ethics. J Empir Res Hum Res Ethics 7(3):1–14
43. Meadow JF, Altrichter AE, Bateman AC, Stenson J, Brown GZ, Green JL, Bohannan BJ (2015) Humans differ in their personal microbial cloud. PeerJ 3:e1258
44. Merlo G, Graves N, Brain D, Connelly L (2016) Economic evaluation of fecal microbiota transplantation for the treatment of recurrent clostridium difficile infection in Australia. J Gastroenterol Hepatol 31(12):1927–1932
45. Nettleton S (2013) The sociology of health and illness, 3rd edn. Polity, Malden
46. Nguyen TL, Vieira-Silva S, Liston A, Raes J (2015) How informative is the mouse for human gut microbiota research? Dis Models Mech 8(1):1–16
47. O’Doherty KC, Virani A, Wilcox ES (2016) The human microbiome and public health: social and ethical considerations. Am J Public Health 106(3):414–420
48. Oh B, Kim BS, Kim JW, Kim JS, Koh SJ, Kim BG, Lee KL, Chun J (2016) The effect of probiotics on gut microbiota during the helicobacter pylori eradication: randomized controlled trial. Helicobacter 21(3):165–174
49. Paramsothy S, Borody TJ, Lin E, Finlayson S, Walsh AJ, Samuel D, van den Bogaerde J, Leong RW, Connor S, Ng W et al (2015) Donor recruitment for fecal microbiota transplantation. Inflamm Bowel Dis 21(7):1600–1606
50. Ravitsky V, Wilfond BS (2006) Disclosing individual genetic results to research participants. Am J Bioeth 6(6):8–17
51. Rhodes R (2013) Introduction: looking back and looking forward. In: The human microbiome: ethical, legal and social concerns, Edited by Prosamond Rhodes, Nada Gligorov, And Abraham Paul Schwab, Oxford University Press
52. Rhodes R (2016) Ethical issues in microbiome research and medicine. BMC Med 14(1):156
53. Rhodes R, Azzouni J, Baumrin SB, Benkov K, Blaser MJ, Brenner B, Dauben JW, Earle WJ, Frank L, Gligorov N et al (2011) De minimis risk: a proposal for a new category of research risk. Am J Bioeth 11(11):1–7
54. Rhodes R, Baumrin SB, Blaser MJ, Earle WJ, Indyk D, Ethylin WJ, Moros DA, Richardson LD, Sacks HS (2013) Public health and research on populations. In: The human microbiome: ethical, legal and social concerns, Edited by Prosamond Rhodes, Nada Gligorov, And Abraham Paul Schwab, Oxford University Press
55. Rodriguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, Avershina E, Rudi K, Narbad A, Jenmalm MC et al (2015) The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis 26:26050
56. Rosamond Rhodes MJB, Dauben JW, Frank LE, Moros DE, Philpott S (2013) Research Ethics. The human microbiome: ethical, legal and social concerns, Edited by Prosamond Rhodes, Nada Gligorov, And Abraham Paul Schwab, Oxford University Press
57. Rubin DT, Becker S, Siegler M (2014) Ethical considerations for clinical trials in inflammatory bowel disease. Gastroenterol Hepatol 10(1):37–41
58. Ruth R (1986) Faden TLB: a history and theory of informed consent. Oxford University Press, New York
59. Sanmiguel C, Gupta A, Mayer EA (2015) Gut microbiome and obesity: a plausible explanation for obesity. Curr Obes Rep 4(2):250–261
60. Schmedes SE, Sajantila A, Budowle B (2016) Expansion of Microbial Forensics. J Clin Microb 54(8):1964–1974
61. Schulfer A, Blaser MJ (2015) Risks of antibiotic exposures early in life on the developing microbiome. PLoS Pathog 11(7):e1004903
62. Schwab AP, Brenner B, Goldfarb J, Hirschhorn R, Philpott S (2013) Biobanks and the human microbiome. In: Rhodes R, Gligorov N, Schwab AP (eds) The human microbiome: ethical, legal and social concerns. Oxford University Press, New York, pp 182–207
63. Schwarz S, Morelli G, Kusecek B, Manica A, Balloux F, Owen RJ, Graham DY, van der Merwe S, Achtman M, Suerbaum S (2008) Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog 4(10):e1000180
64. Seeding V (2017) Committee opinion No. 725. American College of obstetricians and gynecologists. Obstet Gynecol 130:e274–e278
65. Senok AC, Ismaeel AY, Botta GA (2005) Probiotics: facts and myths. Clin Microbiol Infect 11(12):958–966
66. Sharp RR, Achkar J-P, Brinich MA, Farrell RM (2009) Helping patients make informed choices about probiotics: a need for research. Am J Gastroenterol 104(4):809–813
67. Slashinski MJ, McCurdy SA, Achenbaum LS, Whitney SN, McGuire AL (2012) “Snake-oil”, “quack medicine”, and “industrially cultured organisms:” biovalue and the commercialization of human microbiome research. BMC Med Ethics 13:28
68. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS (2013) Guidelines for diagnosis, treatment, and prevention of clostridium difficile infections. Am J Gastroenterol 108(4):478–498
69. Terveer EM, van Beurden YH, Goorhuis A, Seegers JFML, Bauer MP, van Nood E, Dijkgraaf MGW, Mulder CJJ, Vandenbroucke-Grauls CMJE, Verspaget HW et al (2017) How to: establish and run a stool bank. Clin Microbiol Infect 23(12):924–930
70. Torrey FE, Yolken RH (2005) Beasts of the earth: animals, humans, and disease. In: pISCATAWAY, NJ: Rutgers University Press
71. Tosh PK, McDonald LC (2012) Infection control in the multidrug-resistant era: tending the human microbiome. Clin Infect Dis 54(5):707–713
72. Tridico SR, Murray DC, Addison J, Kirkbride KP, Bunce M (2014) Metagenomic analyses of bacteria on human hairs: a qualitative assessment for applications in forensic science. Investig Genet 5(1):1–13
73. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP et al (2009) A core gut microbiome in obese and lean twins. Nature 457(7228):480–484
74. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JFWM, Tijssen JGP et al (2013) Duodenal infusion of donor feces for recurrent clostridium difficile. N Engl J Med 368(5):407–415
75. Varier RU, Biltaji E, Smith KJ, Roberts MS, Kyle Jensen M, LaFleur J, Nelson RE (2015) Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection. Infect Control Hosp Epidemiol 36(4):438–444
76. Walter J, Ley R (2011) The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol 65:411–429
77. Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, Zeng L, Chen J, Fan S, Du X et al (2016) Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry 21(6):786–796